Business

VVT Med Announces Positive Clinical Data for ScleroSafe(R) Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery

Prospective Study Conducted at Holy Spirit Hospital in Mumbai Reports 95% Vein Occlusion Rate at 30VANCOUVER, BC, April 30, 2026 (GLOBE NEWSWIRE) -- VVT Med Inc. (TSXV: VVTM) ("VVT Med" or the "Company"), a developer of minimally invasive, non-thermal, non-tumescent ("NT-NT") solutions for venous disease, is pleased to announce the publication of a peer-reviewed clinical study evaluating the short-term efficacy and safety of its ScleroSafe(R) catheter-directed sclerotherapy system. The study, au

articleVvt Med Inc.April 30, 20265/company/vvt-med-inc/news/vvt-med-announces-positive-clinical-data-for-sclerosafer-published-in-peer-reviewed-indian-journal-of-vascular-and-endovascular-surgery
VVT Med Announces Positive Clinical Data for ScleroSafe(R) Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery

About this update from Vvt Med Inc.

[{"type":"image","alt":"VVT Med Inc.","displaySize":"","headline":null,"caption":"VVT Med Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":123,"url":"https://media.zenfs.com/en/globenewswire.com/1ecc9757aa8409ba9e1ee8b9c8bc8c9f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/diX6V9U9qjwfEEuE.HrDMg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3Mg--/https://media.zenfs.com/en/globenewswire.com/1ecc9757aa8409ba9e1ee8b9c8bc8c9f","width":300,"height":123}},"lazy":false},{"type":"text","content":"Prospective Study Conducted at Holy Spirit Hospital in Mumbai Reports 95% Vein Occlusion Rate at 30","length":99,"tagName":"p"},{"type":"text","content":"VANCOUVER, BC, April 30, 2026 (GLOBE NEWSWIRE) -- VVT Med Inc. (TSXV: VVTM) ("VVT Med" or the "Company"), a developer of minimally invasive, non-thermal, non-tumescent ("NT-NT") solutions for venous disease, is pleased to announce the publication of a peer-reviewed clinical study evaluating the short-term efficacy and safety of its ScleroSafe(R) catheter-directed sclerotherapy system. The study, authored by Dr. Aniruddha Sanjoy Bhuiyan and Dr. Meet Taral Sheth of the Departments of Vascular and Endovascular Surgery and General Surgery at Holy Spirit Hospital and Medical Research Centre in Mumbai, India, was published in the Indian Journal of Vascular and Endovascular Surgery (2026;13:64-66), a peer-reviewed journal published by Wolters Kluwer Medknow.","length":791,"tagName":"p"},{"type":"text","content":"The study, titled "Efficacy and Safety of ScleroSafe Catheter-directed Sclerotherapy for Varicose Veins: A Prospective Observational Study" was published online recently, on The Indian Journal of Vascular and Endovascular Surgery, which is the official publication of the Vascular Society of India and is indexed with Wolters Kluwer Medknow.","length":351,"tagName":"p"},{"type":"text","content":"The prospective observational study enrolled 30 patients treated between March 2025 and July 2025 for symptomatic primary varicose veins at Holy Spirit Hospital and Medical Research Centre in Mumbai. Eligible patients had CEAP class C2 to C5 disease with duplex-confirmed reflux in the great or small saphenous vein and no prior venous interventions on the treated limb. All procedures were performed under ultrasound guidance by a single experienced vas...

More updates from Vvt Med Inc.

Endovascular SurgeryMedical Research CentreVVTThe CompanyHoly Spirit HospitalProspective Observational Studyvenous diseaseMeet Taral ShethAniruddha Sanjoy BhuiyanWolters Kluwer MedknowCompanyvaricose veins